Myriad Genetics (MYGN) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Myriad Genetics (MYGN) over the past year, losing 13.1% versus a loss of 45.0%. Myriad Genetics is the larger company by market cap ($416.6 million vs $114.3 million), about 3.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MYGN | QUCY |
|---|---|---|
| Share price | $4.36 | $1.36 |
| Market cap | $416.55M | $114.33M |
| 1-day change | +3.69% | -2.16% |
| YTD return | -31.71% | +24.11% |
| 1-year return | -45.03% | -13.13% |
| 5-year return | -86.77% | — |
| EPS (TTM) | $-1.18 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.59 | $4.93 |
| 52-week low | $2.74 | $0.30 |
| Distance from 52-week high | -49.30% | -72.41% |
| Analyst consensus | hold | none |
| Avg. price target upside | -10.22% | +561.76% |
| Average volume | 2.04M | 691.24K |
| Shares outstanding | 95.65M | 84.07M |
| Employees | 2,700 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Myriad Genetics is about 3.6 times larger than Quantum Cyber N.V. by market value ($416.55M vs $114.33M).
- QUCY has outperformed MYGN by 31.9 percentage points over the past year.
About Myriad Genetics
MYGN stock →Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 2,700 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
MYGN vs QUCY FAQ
Which is bigger, Myriad Genetics or Quantum Cyber N.V.?
Myriad Genetics (MYGN) is larger, with a market capitalization of $416.55M compared with $114.33M for Quantum Cyber N.V. (QUCY).
Which stock has performed better over the past year, MYGN or QUCY?
QUCY returned -13.13% over the past 12 months, compared with -45.03% for MYGN (price return, excluding dividends). Past performance does not predict future results.
Are Myriad Genetics and Quantum Cyber N.V. in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Myriad Genetics and Biotechnology: Pharmaceutical Preparations for Quantum Cyber N.V..